Travere Therapeutics, Inc. (TVTX) Corporate Subsidiaries
Travere Therapeutics, Inc. (TVTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TVTX
CIK: 1438533
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: CA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerTim Holl
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010273 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-21 | 8-K | 0001438533-26-000068 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001698262-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001789617-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001902368-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001283303-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001763494-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001943192-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001882909-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009642 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009625 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001950047-26-009577 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001950047-26-009576 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001950047-26-009566 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009523 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009521 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009520 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009513 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009510 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009503 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009488 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | 4 Filing | 0001506916-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-09-10 | — | 144 Filing | 0001950047-26-009292 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | 4 Filing | 0001943192-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001123343-26-000010 | View SEC Doc Filr Page |